Skip to content

Effect of Intranasal Insulin on Postoperative Cognitive Dysfunction

Effect of Intranasal Insulin on Postoperative Cognitive Dysfunction in Middle Aged Patients Undergoing Non Cadiac Surgery.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04154449
Enrollment
57
Registered
2019-11-06
Start date
2019-02-25
Completion date
2019-12-25
Last updated
2019-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Middle Aged Patients

Brief summary

Our study is designed to evaluate the effect of intranasal insulin on postoperative cognitive dysfunction. Primary outcome: 1\. The occurrence of cognitive dysfunction at approximately 7 days after surgery. Secondary outcome: 1\. Incidence of any side effect.

Interventions

DRUGIntranasal insulin

Surgical group Received intranasal insulin, the second group surgical Received placebo and the third group is non surgical do not receive anything.

Sponsors

Minia University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

1. Age 40 - 60 years. 2. Both gender. 3. Patients will be scheduled for elective major abdominal, thoracic, orthopedic, open gynecological, open urological, spine, otolaryngological surgeries under general anesthesia with expected hospital stay \>4 days.

Exclusion criteria

* 1\. Drug allergy. 2. Patients with major psychiatric disease. 3. Patients receive major tranquillizers and antidepressant. 4. Those undergoing neurosurgery or cardiac surgery. 5. Those unable or unwilling to abide by the study procedure 6. Those who could not follow procedure or who had poor comprehension of dutch language. 7. Those with sever visual and auditory disorder / handicaps.

Design outcomes

Primary

MeasureTime frameDescription
Cognitive dysfunction7 daysThe occurrence of cognitive dysfunction at approximately 7 days after surgery.

Countries

Egypt

Contacts

Primary ContactNourhan Mohamed Anter
nourhananter1992@yahoo.com01100418846

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026